Increased Levels of Circulating and Tissue mRNAs of Oct-4, Sox-2, Bmi-1 and Nanog is ESCC Patients: Potential Tool for Minimally Invasive Cancer Diagnosis

Increased Levels of Circulating and Tissue mRNAs of Oct-4, Sox-2, Bmi-1 and Nanog is ESCC Patients: Potential Tool for Minimally Invasive Cancer Diagnosis

Show other versions (1)

Bibliographic Details
Main Authors:	Kriti Bahl, Anoop Saraya, Rinu Sharma
Format:	Article
Language:	English
Published:	SAGE Publishing 2012-03-01
Series:	Biomarker Insights
Online Access:	http://la-press.com/increased-levels-of-circulating-and-tissue-mrnas-of-oct-4-sox-2-bmi-1--a3109

Similar Items

Increased Levels of Circulating and Tissue mRNAs of Oct-4, Sox-2, Bmi-1 and Nanog is ESCC Patients: Potential Tool for Minimally Invasive Cancer Diagnosis
by: Kriti Bahl, et al.
Published: (2012-01-01)

Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells
by: Mikella Robinson, et al.
Published: (2021-01-01)

SUMOylation represses Nanog expression via modulating transcription factors Oct4 and Sox2.
by: Yongyan Wu, et al.
Published: (2012-01-01)

Expression patterns of OCT4, NANOG, and SOX2 in goat preimplantation embryos from in vivo and in vitro
by: Xiao-li YU, et al.
Published: (2015-07-01)

Regulation and Expression of Nanog, Oct4, and Sox2 in the Bovine Blastocyst following Somatic Cell Nuclear Transfer
by: Hall, Justin Scott
Published: (2013)

Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas
by: Daniel Pedregal-Mallo, et al.
Published: (2020-07-01)

Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells
by: Schultz Bruce, et al.
Published: (2006-02-01)

Evaluating the Expression of Oct-4, NANOG, Sox2 and Nucleostemin in Colon Cancer Cell Lines (Caco-2 and HT-29)
by: Mohammad Jafar Rezaie, et al.
Published: (2010-01-01)

Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma.
by: Weiren Luo, et al.
Published: (2013-01-01)

Effects of Nanog and Oct4 overexpression on myogenic differentiation
by: I-chen Huang, et al.
Published: (2005)

Correction: Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma
by: Weiren Luo, et al.
Published: (2013-01-01)

Correction: Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma.
by: Weiren Luo, et al.
Published: (2013-01-01)

Effect of High-mobility Group Box-1 on Expression of Stem Cell Markers OCT4, Sox2 and Nanog in Cervical Carcinoma
by: WANG Hua, et al.
Published: (2018-10-01)

Study of SOX2, OCT4 and NANOG Genes Expression in Peripheral Blood of Patients with Non-small Cell Lung Cancer (NSCLC)
by: Niloofar Mojtahedifard, et al.
Published: (2018-01-01)

The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer
by: Sodja Eva, et al.
Published: (2016-06-01)

Association of Oct4, Sox2, Nanog and Lin28 Protein Expression Levels with the Prognosis of Invasive Mammary Ductal Carcinoma Patients
by: Sheng-feng Huang, et al.
Published: (2012)

SOX2 Is Regulated Differently from NANOG and OCT4 in Human Embryonic Stem Cells during Early Differentiation Initiated with Sodium Butyrate
by: Ade Kallas, et al.
Published: (2014-01-01)

Bright/Arid3A Acts as a Barrier to Somatic Cell Reprogramming through Direct Regulation of Oct4, Sox2, and Nanog
by: Melissa Popowski, et al.
Published: (2014-01-01)

Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog)
by: SoHyun Lee, et al.
Published: (2017-04-01)

Oct4 and Nanog cooperative repress terminal myogenic differentiation
by: Kuan-Chin Lang, et al.
Published: (2008)

Association of Oct4, Sox2, and Nanog Expression with Development and Prognosis in Oral Tongue Squamous Cell Carcinoma and Buccal Mucosal Squamous Cell Carcinoma
by: I-chien Hsieh, et al.
Published: (2013)

293FT cells transduced with four transcription factors (OCT4, SOX2, NANOG, and LIN28) generate aberrant ES-like cells
by: Kobayashi H, et al.
Published: (2010-01-01)

Mapping circulating serum miRNAs to their immune-related target mRNAs
by: Nosirov B, et al.
Published: (2017-02-01)

Characterization of super‐enhancer‐associated functional lncRNAs acting as ceRNAs in ESCC
by: Qiu‐Yu Wang, et al.
Published: (2020-09-01)

Potential diagnostic implications of miR-144 overexpression in human oesophageal cancer
by: Priyanka Sharma, et al.
Published: (2016-01-01)

HIF-2α regulates NANOG expression in human embryonic stem cells following hypoxia and reoxygenation through the interaction with an Oct-Sox cis regulatory element.
by: Raffaella Petruzzelli, et al.
Published: (2014-01-01)

HIF-2α regulates NANOG expression in human embryonic stem cells following hypoxia and reoxygenation through the interaction with an Oct-Sox Cis regulatory element
by: Petruzzelli, Raffaella, et al.
Published: (2014)

Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer.
by: Marilesia Ferreira de Souza, et al.
Published: (2017-01-01)

A novel role for minimal introns: routing mRNAs to the cytosol.
by: Jiang Zhu, et al.
Published: (2010-04-01)

Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression
by: Kuroda, Takao
Published: (2011)

The effects of exogenous Oct4 and Nanog to cellular behaviors of colorectal cancer cells
by: Ming-Long Tsai, et al.
Published: (2011)

Increased expression of stemness genes REX-1, OCT4, NANOG, and SOX-2 in women with ovarian endometriosis versus normal endometrium: A case-control study
by: Fatameh Shariati, et al.
Published: (2018-12-01)

Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 Cells
by: Ade Kallas, et al.
Published: (2014-01-01)

Association of Circulating, Inflammatory-Response Exosomal mRNAs With Acute Myocardial Infarction
by: Guo-dong He, et al.
Published: (2021-08-01)

mRNAs translation and tumorigenesis
by: Rocchi, Laura <1982>
Published: (2012)

Autochthonous mouse melanoma and mammary tumors do not express the pluripotency genes Oct4 and Nanog.
by: Caroline Schreiber, et al.
Published: (2013-01-01)

Analysis of the pluripotency of 3T3 firborblasts re-expressed Oct-4 and Nanog in chimeric mice
by: Shian-Shiou Shie, et al.
Published: (2007)

Oct4 and Nanog directly maintain self-renewal and undifferentiated status in mesenchymal stem cells
by: Chih-Chien Tsai, et al.
Published: (2011)

Utility of BMI-1 and NANOG expression levels in survival prediction of pediatric acute lymphoblastic leukemia
by: Sara Abdel-khalek, et al.
Published: (2021-04-01)

To Be or Not to Be: Circular RNAs or mRNAs From Circular DNAs?
by: Leire Iparraguirre, et al.
Published: (2019-10-01)